Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

7 Oct 2011 07:00

RNS Number : 7445P
Carclo plc
07 October 2011
Β 

For immediate release 7 October 2011

Β 

Carclo plc

("Carclo" or "the group")

Β 

Half Year Trading Update

Β 

The group has traded in line with the board's expectations for the first half of the year with a solid performance given the current uncertain economic environment. As previously indicated, a greater proportion of operating profits is expected in the second half of the year.

Β 

In Technical Plastics, profits will as anticipated be slightly behind last year's first half, which was unusually strong due to a number of factors including the timing of tooling profits. The division has benefitted from further growth at its US medical business and the significant expansion of its Indian business. These factors should deliver a stronger second half performance and a continuing growth in profitability for the division in respect of the full year.

Β 

In Precision Products, growth in Wipac's specialist LED supercar lighting business has been positive and we have continued to win new programmes. Profits are ahead of the prior year first half. The withdrawal from the Ford business remains on course to be completed by the end of the financial year allowing Wipac to focus its resources on growth in LED lighting. Our aerospace businesses have traded well and have returned to profit growth.

Β 

The Fine Line Technology project at Conductive Inkjet Technology has made significant progress and the Cambridge pilot line facility is now production ready. The pace of sampling for smartphones and tablets has stepped up as our commercial partner has introduced the technology to the broader market. Production yields on larger format screens are encouraging. The next significant milestone is the commencement of volume production, which we expect in our fourth quarter.

Β 

The group's financial position remains strong. The bank re-financing exercise is well under way, terms have been agreed and we expect to complete this process shortly.

Β 

The board remains confident in the outlook for the full year.

Β 

Β 

- ENDS -

Β 

Enquiries:

Β 

Β 

Β 

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Β 

Robert Brooksbank, Finance Director

Β 

Β 

Β 

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Robert Cook

Β 

Β 

Β 

Notes to editors

Β 

Β·; Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

Β 

Β·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

Β 

Β·; A third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries. Carclo is a leader in the development of high power LED lighting for supercars.

Β 

Β·; Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLFFVLIALRIIL
Date   Source Headline
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.